Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-771

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 63323-771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aza04 0001 01

Chemical structure of Azacitidine, depicting the molecular arrangement of atoms including nitrogen, oxygen, and carbon with standard bond connections shown.*

FDA Label Image

Aza04 0001 02

A survival curve chart comparing the proportion survival over time in months from randomization for two groups labeled CCR and AZA. The chart includes a statistical significance value (Log-Rank p=0.0001) and a hazard ratio with confidence interval (HR=0.58 [95% CI: 0.43-0.77]). A table below the graph shows the number of subjects at risk at various time points for each group.*

FDA Label Image

Aza04 0001 03

Azacitidine 100 mg/30 mL lyophilized powder for solution injection vial label by Fresenius Kabi USA, LLC. The label includes the product name, dosage strength, lyophilized injection form, and instructions for intravenous or subcutaneous use. The vial is clear glass with a purple flip-off cap.*

FDA Label Image

Aza04 0001 04

Label for Azacitidine for Injection 100 mg per vial, a lyophilized powder for solution by Fresenius Kabi USA, LLC. The label states it is for subcutaneous and intravenous use only, single-dose vial, with storage instructions and manufacturer details including Fresenius Kabi, Lake Zurich, IL, and made in India. The NDC number 63323-771-39 and barcode are visible.*

FDA Label Image

Aza04 0001 05

Azacitidine for Injection 100 mg/vial powder, lyophilized for solution, for subcutaneous and intravenous use. Package label includes dosage strength, route of administration, single-dose vial indication, storage instructions, and is labeled by Fresenius Kabi USA, LLC. Product NDC 63323-771-39 is displayed along with barcodes and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.